depressed man with head in handsDepression And Anxiety Symptoms In UK Thalidomide Survivors

Aims

Thalidomide survivors are now in their 50s and 60s and are experiencing a range of secondary health problems, including depression and anxiety. Internationally it is estimated that 40-50% of thalidomide survivors have recently experienced mental health problems.

The aim of this study was to gather data on the pattern of symptoms of depression and anxiety amongst UK thalidomide survivors. This was done using a postal survey of 182 respondents. Where possible, comparisons would be made to information on the general population and other groups with early acquired disabilities.

What was found

The findings suggest that the prevalence of all levels of self-reported depression and generalised anxiety are higher amongst the thalidomide survivors than the general UK population. However, the prevalence of symptoms of depression is broadly similar to other groups of adults with disabling conditions. Although there is substantial evidence that people with disabilities are more likely to report depressive symptoms, the relationship between physical disability and depression is complex. The study also found that being unable to work was associated with higher depression and anxiety scores.

As thalidomide survivors grow older, they are being exposed to a greater range of stressors, notably increasing impairment, secondary health problems, changing social roles such as giving up paid work, and the need for more assistance, which can have profound implications for mental health.

Read the full report of the study

You may also be interested in